Carrier Screening Market Size, Overview, Share and Forecast 2031
The Carrier Screening Market in 2023 is US$ 3.49 billion, and is expected to reach US$ 13.14 billion by 2031 at a CAGR of 18.00%.
FutureWise Research published a report that analyzes Carrier Screening Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Carrier Screening research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Carrier Screening Market Sample
Carrier Screening Market Segmentation:
By Product and Service
- Service
- Product
By Type
- Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
- Targeted Disease Carrier Screening
By Medical Condition
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
By End User
- Hospitals
- Reference Laboratories
- Physician Offices and Clinics
- Others
By Technology
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Major players included in the Carrier Screening Market:
- MedGenome Inc.
- Luminex Corporation
- Illumina Inc
- Otogenetics Corporation
- Myriad Genetics Inc
- Thermo Fisher Scientific Inc.
- Natera Inc
- Gene By Gene Ltd
- Corporation of America Holdings
- Mount Sinai Genomics Inc,
- Eurofins Scientific
- Invitae Corporation
- Opko Health
- Fulgent Genetics Inc
- Quest Diagnostics Incorporated
Please visit full report of the Carrier Screening market @ Visit Carrier Screening Market
Competitive Landscape:
· Tier one players - market players with a significant share of the market
· Tier two players
· Players with rapid growth
· New Entries
FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth
Objectives of the Study:
• To provide report with an in-depth analysis of the Carrier Screening Market By Product and Service, By Type, By Medical Condition, By End User, By Technology and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
• With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian